Shahzad Raza
- Genetics top 2%
- Glioma Diagnosis and Treatment 11
- Chronic Lymphocytic Leukemia Research 10
- Hematology top 5%
- Multiple Myeloma Research and Treatments 31
- Cancer Research top 10%
- Oncology top 10%
- CAR-T cell therapy research 14
- Peptidase Inhibition and Analysis 9
- Neurology top 10%
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 19
- Protein Degradation and Inhibitors 12
-
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- Michael L. GruberJohn G. GolfinosErik ParkerDavid ZagzagAshwatha NarayanaIngeborg FischerEdmond A. KnoppPraveen Medabalmi
- Cited by
- GeneticsHematologyCancer Research
- Journals
- Journal of Clinical Oncology (13 papers)SHILAP Revista de lepidopterología (5 papers)Blood (14 papers)
- Partner nations
- United StatesPakistanUnited Kingdom
In The Last Decade
Shahzad Raza
103 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 97
- Genetics 497
- Hematology 257
- Cancer Research 244
- Oncology 338
- Neurology 149
Countries citing papers authored by Shahzad Raza
This map shows the geographic impact of Shahzad Raza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahzad Raza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahzad Raza more than expected).
Fields of papers citing papers by Shahzad Raza
This network shows the impact of papers produced by Shahzad Raza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahzad Raza. The network helps show where Shahzad Raza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shahzad Raza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 1 | |
| 12 | 2024 | 10 | |
| 13 | 2024 | 1 | |
| 14 | 2023 | 18 | |
| 15 | 2023 | 2 | |
| 16 | 2023 | 11 | |
| 17 | 2022 | 2 | |
| 18 | 2017 | 18 | |
| 19 | 2016 | 20 | |
| 20 | 2008 | 62 |
About Shahzad Raza
Shahzad Raza is a scholar working on Hematology, Genetics and Oncology, having authored 120 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (31 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers), CAR-T cell therapy research (14 papers), Protein Degradation and Inhibitors (12 papers), Glioma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (10 papers), Peptidase Inhibition and Analysis (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). The work is most often cited by research in Genetics (497 citations), Hematology (257 citations) and Cancer Research (244 citations). Shahzad Raza has collaborated with scholars based in United States, Pakistan and United Kingdom. Frequent co-authors include Michael L. Gruber, John G. Golfinos, Erik Parker, David Zagzag, Ashwatha Narayana, Ingeborg Fischer, Edmond A. Knopp, Praveen Medabalmi, Rachael A. Safyan and Patrick D. Kelly. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.